Vivek Naranbhai
- Infectious Diseases top 0.5%
- Immunology top 2%
- Molecular Biology top 10%
- Epidemiology top 5%
- Oncology top 10%
- Co-authors
- Wilfredo F. García-BeltránA. John IafrateAlejandro B. BalazsKerri St. DenisEvan C. LamDavid J. GregoryJared FeldmanMark C. Poznansky
- Topics
- HIV Research and Treatment (19 papers)Immune Cell Function and Interaction (18 papers)Tuberculosis Research and Epidemiology (14 papers)
- Partner nations
- United StatesSouth AfricaUnited Kingdom
In The Last Decade
Vivek Naranbhai
72 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Infectious Diseases 2.4k
- Immunology 1.1k
- Molecular Biology 918
- Epidemiology 682
- Oncology 439
Countries citing papers authored by Vivek Naranbhai
This map shows the geographic impact of Vivek Naranbhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Naranbhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Naranbhai more than expected).
Fields of papers citing papers by Vivek Naranbhai
This network shows the impact of papers produced by Vivek Naranbhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Naranbhai. The network helps show where Vivek Naranbhai may publish in the future.
Co-authorship network of co-authors of Vivek Naranbhai
This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Naranbhai. A scholar is included among the top collaborators of Vivek Naranbhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Naranbhai. Vivek Naranbhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 32 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 3 | |
| 9 | 15 | |
| 10 | T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individualsbreakdown → | 157 |
| 11 | 21 | |
| 12 | 30 | |
| 13 | 10 | |
| 14 | 41 | |
| 15 | 13 | |
| 16 | 21 | |
| 17 | 12 | |
| 18 | 71 | |
| 19 | 14 | |
| 20 | 10 |
About Vivek Naranbhai
Vivek Naranbhai is a scholar working on Virology, Infectious Diseases and Immunology, having authored 78 papers that have together received 4.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (18 papers) and Tuberculosis Research and Epidemiology (14 papers). The work is most often cited by research in Infectious Diseases (2.4k citations), Virology (390 citations) and Immunology (1.1k citations). Vivek Naranbhai has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Wilfredo F. García-Beltrán, A. John Iafrate, Alejandro B. Balazs, Kerri St. Denis, Evan C. Lam, David J. Gregory, Jared Feldman, Mark C. Poznansky, Adam D. Nitido and Blake M. Hauser. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.